Merethe A. Dyrnes

Livsforsikringsselskapet Nordea Liv Norge AS (Nordea Liv) is the life insurance subsidiary of Nordea Life Holding AB, ultimately held by Nordea Bank AB (ST: NDA) in Norway. Tracing their history to 1844, Nordea Liv is the result of a merger between Vesta Liv AS and Norwegian Liv AS. Based in Bergen, Nordea Liv offers collective pension insurance to businesses as well as life and pension insurance to private customers. They distribute through multiple channels including Nordea Bank Norway, Vesta Forsikring AS, insurance brokers and selected independent contractors.

Sparebanken Sogn og Fjordane engages in the provision of banking, investment, personal and home loans, bill payments, overdraft and other financial services. It operates through the following segments: Finance; Corporate Banking, Market, Public Sector, Financial Sector; Retail Market Including Bustadkreditt, Other, Estate Agency, and Property Management. The Finance segment deals with financing and managing liquidity. The Corporate Banking, Market, Public Sector, Financial Sector segment offers financing, deposits, investments, insurances, foreign currency services and interest rate instruments to small and medium-sized enterprises, the public sector and financial sector. The Retail Market Including Bustadkreditt segment provides financial services to retail customers. The Other segment supplies supplies services to Sparebankstiftinga Sogn og Fjordane and manages various properties. The Estate Agency segment refers to estate agency services in conjunction with the purchase and sale of properties. The Property Management segment handles the group’s largest properties. The company was founded in 1842 and is headquartered in Forde, Norway.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.

Orkla Confectionery & Snacks Norge AS manufactures confectionary products. It offers snacks, biscuits, chocolates and candy products. The firm also supplies branded consumer goods and concept solutions to the grocery and out-of-home sectors in the Nordic and Baltic regions. The company was founded in April 2013 and is headquartered in Oslo, Norway.

Deloitte AS provide professional services in audit, consulting, corporate finance, tax and VAT. The firm also offers financial advisory and risk management services. It serves the aviation, defense, automotive, finance, banking, consumer products, healthcare, insurance, life sciences, media, oil and gas, power, real estate, retail, technology, telecommunications, hospitality and government sectors. The company was founded in 1998 and is headquartered in Oslo, Norway.

Part of DNB Bank ASA, DnB NOR Markets ASA is a Norwegian company that provides banking services. The company is based in Aker Brygge, Norway.